ClearPoint Neuro CLPT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $36.52M+195% | $46.97M+134% | $38.4M+78.0% | $41.72M+27.0% | $12.39M-65.0% | ||
| $8.66M+137% | $6.55M+39.0% | $4M+3.2% | $4.26M+22.6% | $3.65M+45.4% | ||
| $8.57M+7,912% | $8.36M+8,016% | $6.58M+3,225% | $6.29M+2,567% | $107K-54.9% | ||
| $54.88M+127% | $63.6M+90.6% | $51.33M+49.5% | $53.99M+16.0% | $24.21M-49.1% | ||
| $2.91M+33.5% | $2.62M+30.7% | $2.11M+24.7% | $2.02M+30.7% | $2.18M+62.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $93.42M+211% | $97.75M+149% | $60.36M+50.2% | $62.87M+19.6% | $30.07M-43.9% | ||
| $2.33M+91.6% | $1.26M-6.3% | $723K-24.3% | $1.53M+86.3% | $1.22M+44.1% | ||
| $1.81M+12.1% | $1.67M-21.3% | $1.72M+160% | $1.38M+31.0% | $1.62M-4.3% | ||
| $9.48M+38.1% | $10.77M+4.0% | $8.05M+6.6% | $7.4M-55.7% | $6.87M-54.7% | ||
| $49.64M— | —— | —— | —— | —— | ||
| $74.58M+640% | $69.73M+405% | $44.48M+297% | $43.13M+111% | $10.08M-47.1% | ||
| 90M0.0% | 90M+32,509% | 90M0.0% | 90M0.0% | 90M0.0% | ||
| -$226.46M-14.7% | -$216.91M-13.3% | -$209.12M-12.4% | -$203.23M-12.3% | -$197.4M-11.8% | ||
| $18.84M-5.7% | $28.02M+10.4% | $15.87M-45.3% | $19.74M-38.6% | $19.99M-42.2% | ||
| $93.42M+211% | $97.75M+149% | $60.36M+50.2% | $62.87M+19.6% | $30.07M-43.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ClearPoint Neuro's total assets?
- ClearPoint Neuro (CLPT) holds $93.4M in total assets, up 210.7% year over year.
- How much debt does ClearPoint Neuro have?
- ClearPoint Neuro carries $63.6M in total debt against $18.8M of shareholders' equity, a debt-to-equity ratio of 3.38.
- How much cash does ClearPoint Neuro have?
- ClearPoint Neuro holds $36.5M in cash and equivalents.
- Can ClearPoint Neuro cover its short-term obligations?
- Its current ratio is 5.79 — current assets exceed current liabilities.
- Where does ClearPoint Neuro's balance sheet data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
